Skip to main content
. 2022 Apr 21;9:858261. doi: 10.3389/fnut.2022.858261

FIGURE 9.

FIGURE 9

TBs-C inhibits the PI3K/AKT/mTOR pathway in vitro. (A) The protein was extracted from tumors in each experimental group, and the expression of p-PI3K, p-AKT, p-mTOR, p21, and LC3 were detected by Western blotting. (B) Density analysis of Western blotting results among the study groups. TBs-C (L), TBs-C low-dose group, TBs-C (H), TBs-C high-dose group, *p < 0.05, **p < 0.01.